Peter H Miller

US Patent:

7850997, Dec 14, 2010

Filed:

Mar 21, 2008

Appl. No.:

12/052940

Inventors:

Tim Romero - Sarasota FL, US
Peter Miller - Broomfield CO, US

International Classification:

A61K 33/00
A61K 9/68
A01N 37/12

US Classification:

424718, 424440, 514561

Abstract:

Various compounds can be administered orally to humans or animals for the purpose of enhancing nitric oxide production. Enhancing nitric oxide production is beneficial for those looking to increase lean body mass or enhance exercise performance. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. L-Arginine and alpha amino n-Butryate work synergistically to enhance nitric oxide production and may further be coupled with either and/or a) an inhibitor of nitric oxide breakdown or b) a nitric oxide potentiators or other precursor and serve to accomplish this goal of enhance nitric oxide. The composition may be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.

US Patent:

8445035, May 21, 2013

Filed:

Nov 28, 2011

Appl. No.:

13/305153

Inventors:

Timothy Romero - Sarasota FL, US
Bolin Qin - Gaithersburg MD, US
Peter J. Miller - Broomfield CO, US

Assignee:

FHG Corporation - Spring Hill TN

International Classification:

A61K 36/00

US Classification:

424725

Abstract:

A dietary supplement composition comprising extract containing at least 20% anthocyanins by dry weight. The extract is derived from the plant. The extract comprises approximately 10%-30% of the dry weight of the composition. A vitamin, weight loss agent, or antioxidant is provided in the composition. The dietary supplement composition is administered orally to promote weight loss.

US Patent:

8613959, Dec 24, 2013

Filed:

Feb 9, 2010

Appl. No.:

12/702753

Inventors:

Tim Romero - Sarasota FL, US
Peter Miller - Broomfield CO, US
Bolin Qin - Gaithersburg MD, US

Assignee:

FHG Corporation - Spring Hill TN

International Classification:

A61K 36/00

US Classification:

424725

Abstract:

Materials derived from are administered orally to humans or animals for the purpose of enhancing creatine transport into skeletal tissue and for purposes of enhancing lean body mass. Enhancing creatine transport through improved insulin signaling is a new method of depositing creatine and enhancing lean body mass. Such administration is also used for enhancing athletic performance and controlling bodyweight and body fat levels. More specifically, such administration is used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material is administered as extracts of and administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.

US Patent:

20060013903, Jan 19, 2006

Filed:

Jul 15, 2005

Appl. No.:

11/182701

Inventors:

Timothy Romero - Sarasota FL, US
Peter Miller - Irvine CA, US

International Classification:

A61K 36/54

US Classification:

424739000

Abstract:

A method for promoting weight loss and/or lowering blood glucose comprises an active material which may be cinnamon, an extract of cinnamon, or a derivative of a cinnamon extract. The active material may be utilized in combination with further active ingredients.

US Patent:

20080242727, Oct 2, 2008

Filed:

Mar 27, 2008

Appl. No.:

12/056662

Inventors:

Tim Romero - Sarasota FL, US
Peter Miller - Broomfield CO, US

International Classification:

A61K 31/164
A61P 21/00

US Classification:

514561

Abstract:

A composition that may include branched chain amino acids, alpha amino n-Butyrate and/or alpha amino-n-valerate works synergistically to enhance lean body mass and prevent body mass breakdown. The composition may also be coupled with other agents to a) provide an increased level of amino acids and/or protein in the body's total pool or b) increase markers for protein translation or decrease markers of protein turnover. The composition may be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks. Increasing lean body mass is import to athletes looking to enhance performance, in the event of certain muscle wasting diseases, and to the general population that loses muscle mass as it ages.

US Patent:

20110052736, Mar 3, 2011

Filed:

Nov 2, 2010

Appl. No.:

12/917626

Inventors:

Timothy Romero - Sarasota FL, US
Peter Miller - Broomfield CO, US

Assignee:

Integrity Nutraceuticals International - Sarasota FL

International Classification:

A61K 36/54
A61K 31/353
A61P 3/10
A61P 3/04
A61P 3/06
A61P 9/12

US Classification:

424739, 514453

Abstract:

A composition containing cinnamon extract reduces and/or eliminates one or more risk factors associated with Syndrome X. The composition also includes optionally one of more components selected from the group consisting of vitamins, cholesterol lowering agents, lipid lowering agents, and glucose lowering agent. Also described is a method of reducing and/or eliminating risk factors associated with Syndrome X in a subject through the administration of the cinnamon extract. The cinnamon extract supplement is administered orally, intravenously, or subcutaneously. In one embodiment, a daily dose of 10-1,000 mg of the cinnamon extract supplement is administered to the subject for a period of 6 weeks to 6 months.

US Patent:

20130046018, Feb 21, 2013

Filed:

Oct 18, 2012

Appl. No.:

13/654813

Inventors:

Tim Romero - Sarasota FL, US
Peter J. Miller - Broomfield CO, US

Assignee:

FHG Corporation d/b/a Integrity Nutraceuticals - Spring Hill TN

International Classification:

A61K 31/19
A61P 43/00

US Classification:

514557

Abstract:

A process for increasing lean body mass in a mammalian subject is provided that includes administering to the subject a purified quantity of maslinic acid, oleanolic acid, or a combination thereof. The administration can be orally and benefits from ingestion of an amino acid source such as dietary protein, oligopeptides, or amino acids. Administration within 2 hours of muscle-degrading exercise or on a daily basis for a period of time increases lean body mass.

US Patent:

20140072659, Mar 13, 2014

Filed:

Nov 12, 2013

Appl. No.:

14/077720

Inventors:

Tim Romero - Sarasota FL, US
Peter J. Miller - Broomfield CO, US
Bolin Qin - Gaithersburg MD, US

Assignee:

FHG Corporation d/b/a Integrity Nutraceuticals - Spring Hill TN

International Classification:

A61K 36/185
A61K 31/155

US Classification:

424725

Abstract:

Materials derived from are administered orally to humans or animals for the purpose of enhancing creatine transport into skeletal tissue and for purposes of enhancing lean body mass. Enhancing creatine transport through improved insulin signaling is a new method of depositing creatine and enhancing lean body mass. Such administration is also used for enhancing athletic performance and controlling bodyweight and body fat levels. More specifically, such administration is used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material is administered as extracts of and administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.